EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease

C Warren Olanow, José A Obeso, Fabrizio Stocchi

Nature Clinical Practice Neurology · 2006-07 · 2 (7) · 382-392

DOI: 10.1038/ncpneuro0222 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Neurology, 2006-07. Verfasst von C Warren Olanow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. warren.olanow@mssm.edu. Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiparkinson AgentsClinical Trials as TopicDopamine AgonistsDyskinesia, Drug-InducedHumansLevodopaParkinson Disease

Substanzen

Antiparkinson AgentsDopamine AgonistsLevodopa

Autor:innen und Institutionen

  • Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. warren.olanow@mssm.edu

Zitieren

APA

Olanow, C. W., Obeso, J. A., & Stocchi, F. (2006). Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature Clinical Practice Neurology, 2(7), 382-392. https://doi.org/10.1038/ncpneuro0222

Vancouver

Olanow CW, Obeso JA, Stocchi F. Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature Clinical Practice Neurology. 2006;2(7):382-392. doi:10.1038/ncpneuro0222

BibTeX
@article{Olanow2006,
  author = {Olanow, C Warren and Obeso, José A and Stocchi, Fabrizio},
  title = {Drug Insight: continuous dopaminergic stimulation in the treatment of Parkinson's disease},
  journal = {Nature Clinical Practice Neurology},
  year = {2006},
  volume = {2},
  number = {7},
  pages = {382--392},
  doi = {10.1038/ncpneuro0222}
}
Kostenlos starten →